Mouse Models for Metabolism & Rare Disease Research

Explore Our Models

Subscribe

Models

Our Products

iPSC Cell Lines

Knockout Cell Lines

Tumor Cell Lines

Adeno-associated Virus (AAV) Standard Capsid

Featured Catalog

Humanized Mouse Models

Humanized Target Gene Models

Humanized Immune System Mouse Models

Tool Mice

Cre Mouse Lines

Disease Models

Autoimmune Disease Models

Ophthalmic Disease Models

Immunodeficient Mouse Models

Metabolic Disease Models

Neurological Disease Models

Oncology & Immuno-oncology Models

Services

Model Generation Techniques

Turboknockout^ᵀᴹ Gene Targeting

Cre-ESCs Gene Editing

Targeted Gene Editing

Genetically Engineered Animals

Transgenic Mice

Transgenic Rats

Transgenic Model Generation

Virus Packaging

Adeno-associated Virus (AAV) Packaging

Adenovirus Packaging

Lentivirus Packaging

Custom Cell Line Services

Induced Pluripotent Stem Cells (iPSCs)

Knockout Cell Lines

Knockin Cell Lines

Overexpression Cell Lines

Point Mutation Cell Lines

Breeding & Supporting Services

BAC Modification

Breeding Services

Cryopreservation & Recovery

Phenotyping Services

Drug Discovery and Development

Antibody Discovery Platform

Therapeutic Area

Alzheimer's Disease (AD)

Parkinson's Disease (PD)

Huntington's Disease (HD)

Blood Brain Barrier (BBB)

Neuropathic Pain

Metabolic & Cardiovascular

Age-Related Macular Degeneration (AMD)

PBMC Humanized Mouse Model

Human Immune System (HIS) Mouse Model

Immunology & Inflammation

Innovative Drug R&D

Therapeutic Antibody Drugs

Monoclonal Antibodies (mAb)

Bispecific Antibodies (BsAb)

AI-Powered AAV Discovery

Cell Immunotherapy

Oligonucleotide Therapy

Fully Human Antibody Library

Neurology Antibodies

Metabolic & Cardiovascular Antibodies

Ophthalmology Antibodies

Oncology Antibodies

Immunology & Inflammation Antibodies

Resources

Blogs & Insight

Events & Webinars

Databases

Rare Disease Data Center

Cell iGeneEditor™ System

About Us

Animal Health & Welfare

Corporate Overview

Facility Overview

Blogs & Insights

Explore the latest in biotech and research, crafted to inspire your next breakthrough.

Metabolism & Obesity

5 Decades of Mouse Models That Shaped Every Major Diabetes Drug We Use Today

The PROTAC Era: From VEPPANU’s Landmark Approval to the Next Generation of CRBN-Targeted Therapies

Breaking the COPD Bottleneck: IL-33/ST2/IL1RAP Breakthroughs and the Power of Humanized Models

Top Reads

Metabolism & Obesity

5 Decades of Mouse Models That Shaped Every Major Diabetes Drug We Use Today

The PROTAC Era: From VEPPANU’s Landmark Approval to the Next Generation of CRBN-Targeted Therapies

Breaking the COPD Bottleneck: IL-33/ST2/IL1RAP Breakthroughs and the Power of Humanized Models

New Updates

Why Eli Lilly is Targeting Nav1.8 and MNK for Next-Gen Pain Therapeutics

Mastering AAV Cardiac Delivery: Serotypes, Promoters, and Ready-to-Use Models

Science (IF=47.3): PIEZO1-Driven Liver Regeneration Research Supported by Cyagen Mouse Models

Accelerating Alzheimer's Research Using Advanced iPSC Platforms

Ready to Elevate Your Research?

Discover how Cyagen can support your research. Let’s start a conversation.

Filter By

All Topics

Animal Science and Quality

Autoimmunity & Inflammation

Cardiovascular Research

Cell & Gene Therapy

Genetic Disorders and Genomics

Immunology

Infectious Diseases & Vaccines

Metabolism & Obesity

Neuroscience

Oncology

Ophthalmology

Precision Medicine & Biomarkers

Rare Diseases

Regenerative Biology

Milestones & Highlights

Filter By

Why Eli Lilly is Targeting Nav1.8 and MNK for Next-Gen Pain Therapeutics

Cell & Gene Therapy

Mastering AAV Cardiac Delivery: Serotypes, Promoters, and Ready-to-Use Models

Regenerative Biology

Science (IF=47.3): PIEZO1-Driven Liver Regeneration Research Supported by Cyagen Mouse Models

Cell & Gene Therapy

Accelerating Alzheimer's Research Using Advanced iPSC Platforms

MND Awareness Day 2026: Overcoming ALS Drug Development Bottlenecks with Predictive In Vivo Tools

The PROTAC Era: From VEPPANU’s Landmark Approval to the Next Generation of CRBN-Targeted Therapies

Beyond TfR1? IGF1R Unlocks Ultra-Rapid BBB Crossing and Superior Muscle siRNA Delivery

Cell & Gene Therapy

Precision AAV Targeting in Muscle Tissue: Key Strategies for Successful Gene Therapy in Muscular Disorders

Autoimmunity & Inflammation

Advancing C5AR1 Drug Development in 2026: How Humanized Mouse Models Support Next-Generation C5AR1 Antagonists

1

2

3

4

5

6

...

19

20

More

Address:

2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US

Tel:

800-921-8930 (8-6pm PST)

+1408-963-0306 (lnt’l)

Fax:

408-969-0336

Email:

inquiry@cyagen.com

Services

HUGO-GT™HUGO-Ab™iPSC Cell Lines Adeno-associated Virus (AAV) Standard Capsid

Drug R&D

Neurology Metabolic Ophthalmology Oncology

About Us

Animal Health & Welfare Corporate Overview Our Team Health Reports

Social Media

Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.

Copyright © 2025 Cyagen. All rights reserved.

Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)

Key Insights

The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.

Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.

Now Available for Download

Stay Updated with the Latest from Cyagen

Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.

Full Name

Email

Organization

Country

Areas of Interest

Main Area of Research